Adaptive Clinical Trials
The goal of this 2-year project is to advance the Finnish drug discovery research and its innovations by developing a new concept of adaptive clinical trials. Finland is home to numerous innovations in oncology and cancer therapeutics. However, only a few of these innovations currently reach clinical practice where they would benefit cancer patients.
The TEHO project aims to develop a new, faster and more efficient, adaptive approach to clinical trials which constitute one major bottleneck in transforming Finnish innovations in cancer research into new, effective therapeutics.
Read the entire article here.